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Research
Ground-level ozone (O3) and fine particulate 
matter [≤ 2.5 µm in aerodynamic diameter 
(PM2.5)] have increased substantially since 
preindustrial times. Although O3 and PM2.5 
concentrations have increased most in indus-
trialized areas, observations show that back-
ground concentrations have also increased 
in remote regions (Akimoto 2003; Schultz 
et al. 2006; Staehelin et al. 2001; Vingarzan 
2004; Volz and Kley 1988). O3 and PM2.5 
are associated with negative health impacts, 
including premature mortality (e.g., Jerrett 
et al. 2009; Krewski et al. 2009). Cohen 
et al. (2004) estimated that about 800,000 
annual premature deaths globally, or 1.2% of 
all deaths, are associated with urban outdoor 
PM2.5. This was considered an underestimate 
because it excludes O3 impacts and includes 
only urban areas for which econometric 
models trained with observations were used 
to predict concentrations.
We estimated the global burden of 
human mortality due to anthropogenic O3 
and PM2.5 using a global atmospheric chemi-
cal transport model (CTM). Using an atmo-
spheric CTM allows estimation of mortality 
where air quality measurements are sparse, 
particularly in developing nations. By simu-
lating pre  industrial concentrations, we also 
isolated mortality due to anthropogenic pol-
lution and avoided making assumptions for 
background O3 and PM2.5 concentrations. 
Global CTMs have been used to estimate 
mortalities due to long-range transport of air 
pollution (Anenberg et al. 2009; Liu et al. 
2009; West et al. 2009), future changes in 
emissions (West et al. 2006, 2007), or 
changes in one sector’s emissions (Corbett 
et al. 2007). CTMs have not been used previ-
ously to quantify the global burden of anthro-
pogenic air pollution on human mortality.
Materials and Methods
We calculated mortalities associated with 
anthropogenic air pollution using health 
impact functions that relate changes in pol-
lutant concentrations to changes in mortal-
ity. We defined anthropogenic air pollution 
as the geographically distributed difference 
between present-day (2000) and preindustrial 
O3 and PM2.5 concentrations, as simulated 
by a global CTM. Health impact functions 
for both O3 and PM2.5 are based on a log-
linear relationship between relative risk (RR) 
and concentrations defined by epidemiology 
studies (e.g., Jerrett et al. 2009; Krewski et al. 
2009):
  RR = expβΔX,  [1]
where β is the concentration–response factor 
(CRF; i.e., the estimated slope of the log-
linear relation between concentration and 
mortality) and ΔX is the change in concen-
tration. The fraction of the disease burden 
attributable to the risk factor, the attributable 
fraction (AF), was defined as
  exp 1 AF RR
RR 1 = - =- bDV - .  [2]
AF was multiplied by the baseline mortal-
ity rate (y0) and size of the exposed population 
(Pop) to yield an estimate of the excess mor-
talities attributable to air pollution (ΔMort):
	Δ Mort = y0(1 – exp–βΔX)Pop.  [3]
Disease survival time varies among popu-
lations, and we calculated years of life lost 
(YLL) associated with mortalities using the 
baseline YLL (YLL0) per death:
	Δ YLL = ΔMort × YLL0/y0.  [4]
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Ba c k g r o u n d: Ground-level concentrations of ozone (O3) and fine particulate matter [≤ 2.5 µm in 
aerodynamic diameter (PM2.5)] have increased since preindustrial times in urban and rural regions 
and are associated with cardiovascular and respiratory mortality. 
oBjectives: We estimated the global burden of mortality due to O3 and PM2.5 from anthropogenic 
emissions using global atmospheric chemical transport model simulations of preindustrial and 
present-day (2000) concentrations to derive exposure estimates. 
Me t h o d s : Attributable mortalities were estimated using health impact functions based on long-
term relative risk estimates for O3 and PM2.5 from the epidemiology literature. Using simulated 
concentrations rather than previous methods based on measurements allows the inclusion of rural 
areas where measurements are often unavailable and avoids making assumptions for background air 
pollution. 
re s u l t s: Anthropogenic O3 was associated with an estimated 0.7 ± 0.3 million respiratory mor-
talities (6.3 ± 3.0 million years of life lost) annually. Anthropogenic PM2.5 was associated with 
3.5 ± 0.9 million cardiopulmonary and 220,000 ± 80,000 lung cancer mortalities (30 ± 7.6 million 
years of life lost) annually. Mortality estimates were reduced approximately 30% when we assumed 
low-concentration thresholds of 33.3 ppb for O3 and 5.8 µg/m3 for PM2.5. These estimates were 
sensitive to concentration thresholds and concentration–mortality relationships, often by > 50%. 
co n c l u s i o n s: Anthropogenic O3 and PM2.5 contribute substantially to global premature mortality. 
PM2.5 mortality estimates are about 50% higher than previous measurement-based estimates based 
on common assumptions, mainly because of methodologic differences. Specifically, we included rural 
populations, suggesting higher estimates; however, the coarse resolution of the global atmospheric 
model may underestimate urban PM2.5 exposures.
key w o r d s : air pollution, atmospheric chemistry model, health effects of air pollution, 
health impact analysis, ozone, particulate matter. Environ Health Perspect 118:1189–1195 
(2010).  doi:10.1289/ehp.0901220 [Online 9 April 2010]Anenberg et al.
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For O3, we based CRFs on the associa-
tion between long-term O3 exposure and RR 
of death from respiratory disease found by 
Jerrett et al. (2009) in an American Cancer 
Society (ACS) cohort study of U.S. adults 
≥ 30 years of age for 1977–2000. Although 
many daily time-series epidemiology studies 
demonstrate short-term O3-mortality impacts 
(e.g., Bell et al. 2004), Jerrett et al. (2009) 
provide the first clear evidence for long-term 
impacts. For the two-pollutant model that 
controlled for PM2.5, a 10-ppb increase in the 
seasonal (April–September) average daily 1-hr 
maximum O3 (concentration range, 33.3–
104.0 ppb) was associated with a 4% [95% 
confidence interval (CI), 1.3–6.7%] increase 
in RR of death from respiratory disease.
For PM2.5, we used RRs from Krewski et al. 
(2009), which is the latest reanalysis of the ACS 
PM2.5 studies (e.g., Pope et al. 2002) and has 
the largest population of the available PM2.5 
cohort studies (e.g., Hoek et al. 2002; Laden 
et al. 2006). We used RRs for 1999–2000 
from the random-effects Cox model analysis 
that adjusted for 44 individual-level and seven 
ecological covariates. A 10-µg/m3 increase in 
PM2.5 (concentration range, 5.8–22.2 µg/m3) 
was associated with 6% (95% CI, 4–8%), 13% 
(95% CI, 10–16%), and 14% (95% CI, 
6–23%) increases in total, cardiopulmonary, 
and lung cancer mortality. The linearity of the 
concentration–response function was also dem-
onstrated up to 30 µg/m3 in the 1979–1983 
analysis. Krewski et al. (2009) found that PM2.5 
was associated most strongly with risk of death 
from ischemic heart disease, a subset of cardio-
pulmonary disease, and previous studies have 
found that controlling for O3 concentrations 
had little effect on the PM2.5–mortality rela-
tionships (Krewski et al. 2000). Compared with 
the relationships in an earlier expert elicitation 
(Roman et al. 2008), the total mortality RR in 
Krewski et al. (2009) is generally 3–14% lower 
per 10-µg/m3 increase with a tighter CI.
We assumed that these relationships 
found in the United States are valid globally. 
For O3, Jerrett et al. (2009) is the first study 
showing significant long-term impacts, but 
the short-term impact has been well docu-
mented in North America and Europe (e.g., 
Anderson et al. 2004; Bell et al. 2004). For 
PM2.5, similar long-term mortality results 
have been demonstrated in Europe (Hoek 
et al. 2002), but to date no PM2.5 cohort 
studies have been conducted in the developing 
world. Short-term O3 and PM2.5 studies in 
developing nations demonstrate relationships 
that are generally comparable with short-term 
studies in North America and Europe (Health 
Effects Institute International Scientific 
Oversight Committee 2004). Our assump-
tion is further supported by evidence that 
concentration–mortality relationships do not 
vary significantly by sex, age, and race (Jerrett 
et al. 2009; Krewski et al. 2009; Zanobetti 
et al. 2000), although some sensitive popula-
tions may be at a higher risk. Because global 
causes of death differ from those in North 
America and Europe, we emphasized cause-
specific mortality, which may have less error 
than estimates of all-cause mortality across 
different populations.
We used present-day (2000) and pre-
industrial O3 and PM2.5 concentrations 
(Figure 1) simulated by Horowitz (2006) 
using the Model of Ozone and Related 
Chemical Tracers, version 2 (MOZART-2; 
Horowitz et al. 2003). The preindustrial simu-
lation, which corresponds to the 1860 simu-
lation by Horowitz (2006), represents the 
“background” O3 and PM2.5 present in the 
absence of anthropogenic emissions, allowing 
us to isolate the anthropogenic contributions 
to concentrations and premature mortalities. 
MOZART-2 has a resolution of 2.8° latitude 
by 2.8° longitude with 34 vertical levels, and 
we used concentrations in the first vertical level 
as surface concentrations. Both simulations 
used the same meteorology from the National 
Center for Atmospheric Research Community 
Climate Model to isolate the impact of emis-
sion changes on concentration. We defined 
PM2.5 as all simulated sulfate (SO4), nitrate 
(NO3), ammonium, black carbon (BC), and 
primary organic carbon (OC). We excluded 
dust, sea salt, and secondary organic aerosols, 
which we assumed are unchanged from pre-
industrial to present. We multiplied OC mass 
by 1.4 to account for associated species other 
than carbon, and assumed all SO4 and NO3 
exists as ammonium sulfate [(NH4)2SO4] and 
ammonium nitrate (NH4NO3), following 
Ginoux et al. (2006). For the preindustrial 
case, fossil fuel–burning emissions were set to 
zero and emissions from burning of bio  fuels, 
savannah, tropical forests, and agricultural 
waste were assumed to be 10% of 1990 values.
Consistent with the epidemiology studies, 
we used seasonal average 1-hr daily maximum 
concentrations for O3 and annual average 
Figure 1. Estimated change (present minus preindustrial) in seasonal average (6-month) 1-hr daily maxi-
mum O3 concentrations (ppb; A) and annual average PM2.5 (µg/m3; B) from Horowitz (2006) simulations.
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concentrations for PM2.5. Because high O3 
occurs during different months globally, 
for each grid cell, we found the consecutive 
6-month period with the highest average of 
the simulated daily 1-hr maximum O3 con-
centrations, which we then used to calculate 
annual mortalities. Table 1 shows that the 
modeled global population-weighted seasonal 
average 1-hr daily maximum O3 increased by 
37.1 ppb (from 19.6 ppb in 1860 to 56.7 ppb 
in 2000), using the present population, and 
the global population-weighted annual aver-
age PM2.5 increased by 15.0 µg/m3 (from 
1.1 µg/m3 in 1860 to 16.1 µg/m3 in 2000). 
Globally, OC, BC, NO3, and SO4 are 62.3%, 
6.3%, 0.3%, and 31.0% of total PM2.5 in 
1860 and 45.6%, 9.1%, 4.9%, and 40.4% 
in 2000 [see Supplemental Material, Figure 1 
(doi:10.1289/ehp.0901220)].
We compared modeled present-day surface 
O3 concentrations with data from the National 
Oceanic and Atmospheric Administration 
(NOAA) Earth Systems Research Laboratory 
Global Monitoring Division (NOAA 2008)   
monitoring network (mean bias = 2.5 ppb) 
for 11 remote locations around the world 
and from three nonurban networks: the 
Clean Air Status and Trends Network (U.S. 
EPA 2007) for the United States (mean bias 
= 2.9 ppb), the European Monitoring and 
Evaluation Programme (Convention on Long-
Range Transboundary Air Pollution 2007) for 
Europe (mean bias = –0.2 ppb), and the Acid 
Deposition Monitoring Network in East Asia 
(EANET 2007) for Japan (mean bias = 0.4 
ppb) [see Supplemental Material, Figures 2–5 
(doi:10.1289/ehp.0901220)]. Horowitz 
(2006) found that simulated preindustrial O3 
concentrations overestimate reconstructed 
observations from the late 19th century by 
approximately 5–10 ppb, with strong sensitiv-
ity to assumed biomass burning. Modeled sur-
face PM2.5 concentrations were compared with 
observations by Ginoux et al. (2006) and were 
generally found to be estimated within a fac-
tor of 2 in remote locations and at non  urban 
stations in Europe and the United States, 
with a tendency to be overestimated. These 
comparisons show that MOZART-2 simu-
lates surface O3 and PM2.5 well for nonurban 
and remote measurements in the areas com-
pared, and it was not apparent that corrections 
for bias were necessary. Although simulated 
concentrations were not systematically biased 
outside of urban regions, the coarse resolution 
used here (grid cell area = 9.9 × 104, 8.6 × 104, 
and 5.2 × 104 km2 at 0°, 30°, and 60° latitude) 
may cause errors in mortality estimates, par-
ticularly in urban areas with strong population 
and concentration gradients.
We estimated global premature mortali-
ties separately for O3 and PM2.5 by apply-
ing Equation 3 in each of the MOZART-2 
surface grid cells, using the corresponding 
population and baseline mortality rates for 
each cell. To calculate mortality, we used the 
global 2006 population (Oak Ridge National 
Laboratory 2008) [see Supplemental Material, 
Figure 6 (doi:10.1289/ehp.0901220)], and, 
consistent with the ACS study population, 
we used the population fraction ≥ 30 years 
of age (Table 1), estimated in 14 world 
regions [World Health Organization (WHO) 
2004] [see Supplemental Material, Figure 7 
(doi:10.1289/ehp.0901220)]. We used base-
line all-cause, cardiopulmonary, and lung 
cancer mortality rates for 14 world regions 
(WHO 2004) and 66 countries (WHO 
2008a), back-calculating from regional rates 
where country-specific rates were unavailable 
[Table 1; see also Supplemental Material, 
Figures 8–11 (doi:10.1289/ehp.0901220)]. 
Country-specific mortality rates are broadly 
categorized with no cutoff at 30 years of 
age, and we used rates for the population 
≥ 25 years of age, assuming that differences 
between the rates are insignificant. We used 
baseline YLL rates for the population ≥ 30 
years of age in 14 world regions [global aver-
age = 7.89, 9.77, and 8.93 for cardiopulmo-
nary disease, respiratory disease, and lung 
cancer; see Supplemental Material, Table 1 
(doi:10.1289/ehp.0901220)], assuming a 3% 
discount rate and nonuniform age weight-
ing, giving less weight to years lived at older 
ages (WHO 2008b). We gridded baseline 
mortality rates, baseline YLL, and the frac-
tion of the population ≥ 30 years of age to 
the MOZART-2 grid, and for grid cells over-
lapping multiple countries, we calculated 
area-weighted averages using a geographic 
information system program.
We present results as means ± 1 SD, calcu-
lating uncertainty from 500 Monte Carlo simu-
lations that randomly sampled from normal 
distributions of the CRF, as reported by the 
epidemiology studies, and modeled present-day 
concentrations (SD = 25% of simulated value). 
Although the epidemiology literature provides 
little evidence for low-concentration thresh-
olds (LCTs) or high-concentration thresh-
olds (HCTs) for either O3 or PM2.5 (Jerrett 
et al. 2009; Krewski et al. 2009; Schwartz 
and Zanobetti 2000), mortality relationships 
beyond measured concentrations are unknown. 
Therefore, we estimated mortalities with and 
without assuming LCTs below which O3 and 
PM2.5 are assumed to have no effect on mortal-
ity. For O3, we applied an LCT of 33.3 ppb, 
the lowest measured level in Jerrett et al. 
(2009). When applied, this threshold replaced 
the natural background everywhere except in 
some grid cells in Asia and South America, 
where preindustrial concentrations exceeded 
the threshold (Table 1). We also examined an 
LCT of 56 ppb, which Jerrett et al. (2009) 
found to be close to statistical significance at an 
α-level of 5% (p = 0.0600). The 56-ppb thresh-
old exceeded preindustrial concentrations in all 
cells. Because no grid cells exceeded the high-
est measured level (104.0 ppb) in Jerrett et al. 
(2009), we did not apply an HCT for O3. For 
PM2.5, we applied an LCT of 5.8 µg/m3, the 
lowest measured level in Krewski et al. (2009), 
which exceeded preindustrial concentrations in 
all grid cells (Table 1), effectively replacing the 
natural background. Some grid cells in Europe 
and Asia exceeded the highest measured level 
(30.0 µg/m3) in Krewski et al. (2009), and we 
examined HCTs of 30 µg/m3 and 50 µg/m3 in 
the sensitivity analysis. These thresholds applied 
only to our definition of PM2.5 and would 
be affected by including dust, sea salt, and   
secondary organic aerosols.
Table 1. Population ≥ 30 years of age, average baseline mortality rates, and population-weighted average and range of the seasonal average (6-month) 1-hr daily 
maximum O3 concentrations and annual average PM2.5 concentrations from MOZART-2 simulations of preindustrial (1860) and present-day (2000) levels. 
Baseline mortality rates 
(%/year)c
O3 (ppb)a PM2.5 (µg/m3)a
Pop ≥ 30b 
(billions)
1860 2000 1860 2000
Respiratory CP LC Average Range Average Range Average Range Average Range
Africa 0.28 0.206 0.739 0.011 23.32 11.4–31.9 54.46 20.2–71.5 0.92 0.28–3.19 7.50 0.50–13.9
North America 0.27 0.081 0.502 0.071 21.42 12.5–32.3 59.75 27.0–89.3 1.50 0.14–4.65 8.44 0.31–16.6
Europe 0.44 0.127 1.22 0.056 18.26 15.2–27.5 48.92 32.3–74.3 0.93 0.11–2.96 14.77 0.40–39.0
Asia 1.8 0.171 0.746 0.037 18.91 6.15–35.9 59.64 10.8–83.7 1.19 0.23–3.06 20.41 0.34–55.9
South America 0.15 0.121 0.515 0.025 18.44 12.2–35.8 44.59 22.3–90.3 1.00 0.33–3.89 6.35 0.40–13.9
Oceania 0.02 0.074 0.346 0.035 13.37 3.74–22.8 26.75 6.41–44.4 0.96 0.22–2.27 2.59 0.25–5.01
World 2.9 0.134 0.754 0.042 19.61 3.74–35.9 56.70 6.41–90.3 1.13 0.11–3.89 16.11 0.25–55.9
Abbreviations: CP, cardiopulmonary; LC, lung cancer; Pop, population. Data are average and range for the highest and lowest individual grid cells.
aSimulated by Horowitz (2006). bPopulation ≥ 30 years of age for the year 2006 from the LandScan database (Oak Ridge National Laboratory 2008). cBaseline mortality rates are country 
specific for the latest year after 2000 with data available (WHO 2008a). Where country-specific rates after the year 2000 were not available, we back-calculated country-specific rates 
from regional rates for the year 2002. Anenberg et al.
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Results
With no upper or lower concentration thresh-
old, anthropogenic O3 was estimated to result 
in about 0.7 ± 0.3 million respiratory mor-
talities annually worldwide (Table 2), corre-
sponding to 6.3 ± 3.0 million YLL (Table 3). 
Estimated global respiratory mortalities 
were reduced by approximately 33% when 
we assumed an LCT of 33.3 ppb, the low-
est meas  ured level in Jerrett et al. (2009). 
Regardless of threshold assumption,  > 75% 
of O3 mortalities were estimated to occur 
in Asia, which is densely populated and 
highly polluted, whereas only approximately 
5% occurred in North America. Estimated 
excess O3 mortalities were densest in highly 
populated areas but were distributed more 
evenly across the globe when divided (nor-
malized) by population size (Figure 2).
Assuming no upper or lower concen-
tration threshold, we estimated that expo-
sure to anthropogenic PM2.5 results in 3.5 
± 0.9 million cardiopulmonary mortalities 
and 220,000 ± 80,000 lung cancer mortali-
ties annually (Table 2), corresponding to 28 
± 6.8 and 2.2 ± 0.8 million YLL (Table 3). 
With an LCT of 5.8 µg/m3, estimated cardio-
pulmonary and lung cancer mortalities 
decreased by approximately 28%. Regardless 
of threshold, about 75% of excess mortalities 
occurred in Asia because of high PM2.5 con-
centrations and dense population, followed 
by Europe (17%). As for O3, estimated PM2.5 
mortalities were densest in highly popu-
lated areas but more localized because of the 
shorter atmospheric lifetime of PM2.5 com-
pared with O3 (Figures 1, 3). The highest 
estimated mortalities per million people were 
in Europe, East Asia, and the eastern United 
States (Figure 3B,D), owing to large baseline 
cardiopulmonary and lung cancer mortality 
rates and high PM2.5 concentrations.
Applying an LCT of 25 ppb for O3 
resulted in approximately 14% fewer estimated 
respiratory mortalities than when assum-
ing no upper or lower threshold (Table 4). 
With CRFs from the single-pollutant model 
in Jerrett et al. (2009), which did not con-
trol for PM2.5, O3-mortality estimates were 
approximately 25% lower, corresponding to 
the relative magnitudes of the CRFs. Applying 
the 56-ppb LCT from the threshold model 
reduced mortality estimates by approximately 
75%. For PM2.5, RRs from Krewski et al. 
(2009) are similar to the 1979–1983 and 
1999–2000 average all-cause and lung cancer 
RRs from Pope et al. (2002) but are approxi-
mately 40% higher for cardiopulmonary mor-
tality, thus causing a corresponding increase in 
our estimates when applied [Table 5; see also 
Supplemental Material, Table 2 (doi:10.1289/
ehp.0901220)]. Using RRs from Laden et al. 
(2006)—an extended reanalysis of the Harvard 
Six Cities cohort study that found significantly 
higher RRs than did Krewski et al. (2009)—
increased estimated cardiopulmonary and lung 
cancer mortalities by approximately 30% and 
50%, respectively. With no LCT, applying 
HCTs of 30 µg/m3 and 50 µg/m3 decreased 
estimated mortalities by approximately 10% 
and 1%, with larger decreases estimated for 
Europe and Asia, where some modeled concen-
trations exceeded the upper threshold   values.
Table 2. Estimated annual mortalities ± 1 SD due to anthropogenic O3 and PM2.5, assuming natural back-
ground only or LCTs (33.3 ppb for O3 and 5.8 µg/m3 for PM2.5) (× 1,000).
O3 respiratory PM2.5 cardiopulmonary PM2.5 lung cancer
Background Threshold Background Threshold Background Threshold
Africa 63 ± 34 45 ± 30 154 ± 44 52 ± 33 3 ± 1 1 ± 1
North America 35 ± 17 25 ± 15 124 ± 37 65 ± 30 17 ± 7 10 ± 5
Europe 41 ± 21 23 ± 17 586 ± 149 383 ± 143 47 ± 17 31 ± 14
Asia 543 ± 253 370 ± 220 2,584 ± 618 1,991 ± 603 152 ± 53 122 ± 47
South America 18 ± 9 8 ± 6 48 ± 15 16 ± 9 2 ± 1 1 ± 1
Oceania 1 ± 1 0 ± 0 2 ± 1 0 ± 0 0 ± 0 0 ± 0
World 700 ± 335 470 ± 288 3,499 ± 864 2,506 ± 816 222 ± 80 164 ± 68
SDs reflect uncertainty in the CRF and simulated present-day concentrations (SD = 25% of simulated concentration).
Table 3. Estimated annual YLL ± 1 SD due to anthropogenic O3 and PM2.5, assuming the natural back-
ground or LCTs (33.3 ppb for O3 and 5.8 µg/m3 for PM2.5) (× 1,000).
O3 respiratory PM2.5 cardiopulmonary PM2.5 lung cancer
Background Threshold Background Threshold Background Threshold
Africa 901 ± 486 644 ± 429 1,694 ± 484 572 ± 363 40 ± 13 13 ± 13
North America 285 ± 138 203 ± 122 804 ± 240 421 ± 194 152 ± 62 89 ± 45
Europe 243 ± 125 136 ± 101 4,336 ± 1,103 2,834 ± 1,058 472 ± 171 311 ± 141
Asia 4,322 ± 2,014 2,945 ± 1,751 20,620 ± 4,932 15,888 ± 4,812 1,594 ± 556 1,280 ± 493
South America 137 ± 68 61 ± 46 365 ± 114 122 ± 68 19 ± 10 10 ± 10
Oceania 7 ± 7 0 ± 0 11 ± 6 0 ± 0 0 ± 0 0 ± 0
World 6,251 ± 2,992 4,197 ± 2,572 27,607 ± 6,817 19,772 ± 6,438 2,169 ± 782 1,602 ± 664
SDs reflect uncertainty in the CRF and simulated present-day concentrations (SD = 25% of simulated concentration).
Figure 2. Estimated annual premature mortalities attributed to anthropogenic O3 when no upper or lower concentration threshold is assumed, for respiratory mor-
talities per 1,000 km2 (A) and rate of respiratory mortalities per 106 people (B).
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Discussion and Conclusions
We estimated the global burden of mortality 
due to anthropogenic O3 and PM2.5 using a 
global atmospheric CTM and health impact 
functions. Anthropogenic O3 was associ-
ated with about 0.7 ± 0.3 million respiratory 
mortalities (1.1% ± 0.5% of all mortalities) 
and 6.3 ± 3.0 million YLL annually when 
we assumed no upper or lower concentration 
threshold. Anthropogenic PM2.5 was asso-
ciated with about 3.5 ± 0.9 million cardio-
pulmonary (5.6% ± 1.4% of all mortalities) 
and 220,000 ± 80,000 lung cancer mortali-
ties (0.4% ± 0.1% of all mortalities) annually 
when we assumed no threshold, correspond-
ing to 30 ± 7.6 million YLL. Global mor-
talities were reduced by approximately 30% 
when we assumed LCTs of 33.3 ppb for O3 
and 5.8 µg/m3 for PM2.5, the lowest measured 
levels in Jerrett et al. (2009) and Krewski et al. 
(2009). Estimated excess mortalities were 
densest in highly populated areas but also 
occurred in rural areas that have been affected 
by the increased regional or global back-
ground of air pollution since pre  industrial 
times. These estimates based only on cardio-
pulmonary and lung cancer mortality may be 
conservative because O3 and PM2.5 may also 
affect other causes of mortality. In addition, to 
be consistent with the ACS study population, 
we included only the population ≥ 30 years of 
age, but evidence suggests that O3 and PM2.5 
affect health negatively for all ages, includ-
ing the very young [see U.S. Environmental 
Protection Agency (EPA) 2008 and references 
therein].
Estimated PM2.5 mortalities were five 
times O3 mortalities, suggesting that PM2.5 is 
the dominant contributor to the global health 
burden of outdoor air pollution. To minimize 
double counting of mortalities, we applied 
long-term RRs for O3 and PM2.5 based on 
the same ACS cohort. PM2.5 RRs have been 
shown to be independent from O3 concentra-
tions (Krewski et al. 2000), and we used O3 
RRs from Jerrett et al. (2009) that controlled 
for PM2.5. Furthermore, Jerrett et al. (2009) 
and Krewski et al. (2009) reported that 
PM2.5-related mortality was dominated by 
cardiovascular mortality, whereas O3 was pri-
marily associated with respiratory mortality. 
The independence of the exposure–response 
relationships and the difference in domi-
nant biological mechanisms of mortality for 
each pollutant imply that double counting is 
unlikely to be significant. If these implications 
are correct, O3 and PM2.5 mortalities may be 
summed together to yield total mortalities; 
otherwise, summing the results would over-
estimate total mortalities.
Mortality estimates were sensitive to 
concen  tration thresholds and concentration–
mortality relationships, often changing by 
> 50% of the estimated value under differ-
ent assumptions. We assumed that the CRFs 
found by epidemiology studies conducted in 
North America apply globally, despite differ-
ences in health status, lifestyle, age structure, 
and medical care, and emphasize cause-specific 
Figure 3. Estimated annual premature mortalities attributed to anthropogenic PM2.5 when no upper or lower concentration threshold is assumed, for cardio-
pulmonary mortalities per 1,000 km2 (A), rate of cardiopulmonary mortalities per 106 people (B), lung cancer mortalities per 1,000 km2 (C), and rate of lung cancer 
mortalities per 106 people (D).
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mortality. The CRFs used here could also be 
subject to confounders, including tempera-
ture (Jerrett et al. 2009). Although some evi-
dence suggests differential toxicity of PM2.5 
components (Franklin et al. 2008; Ostro et al. 
2010), we assumed that all PM2.5 species exert 
effects similar to aggregated PM2.5, despite 
differences in PM2.5 composition through-
out the world. These assumptions, although 
necessary because of limited data, may have 
substantial impacts on the results.
Using the same assumptions for CRFs 
(Pope et al. 2002 for 1979–1983) and LCTs 
[7.5 µg/m3, applied to total PM2.5 in Cohen 
et al. (2004), but here only to the species in 
our definition of PM2.5], our mortality esti-
mates for urban and rural areas (Table 5) were 
approximately 50% higher than the previous 
estimate of 800,000 mortalities from urban air 
pollution reported by Cohen et al. (2004). The 
discrepancy results from two competing dif-
ferences in methods. First, we included rural 
populations, which were excluded by Cohen 
et al. (2004). Because the urban population 
in Cohen et al. (2004) is approximately 30% 
of the total global population, and air pollu-
tion has increased in rural regions, including 
rural populations suggests many more air pol-
lution mortalities globally. Second, we used 
a coarse-resolution global CTM that spread 
emissions across large grid cells. Although 
rural O3 and PM2.5 were well simulated, the 
coarse resolution may suppress high urban 
PM2.5 concentrations, causing underestimates 
of PM2.5 mortalities. Compared with a previ-
ous U.S. estimate of 144,000 PM2.5 mortali-
ties (all causes) found using a regional CTM 
(U.S. EPA 2009), our estimate of PM2.5 mor-
talities in North America is similar but slightly 
lower (by 2% for cardiopulmonary and lung 
cancer mortalities and 7% for all-cause mor-
talities). The coarse-resolution model may 
either overestimate or underestimate O3 pol-
lution in urban areas because O3 precursors 
were diluted into a large volume. Previous 
studies have found that regional O3 can be 
overestimated by 13% at the resolution used 
here but that background concentrations are 
not greatly affected by resolution (Wild and 
Prather 2006). A finer-resolution model would 
capture urban populations and concentrations 
more accurately, but adequate resolution is not 
currently possible in global air quality models.
Despite these limitations, this study high-
lights regions where improvements to air 
quality may be particularly effective at reduc-
ing mortality related to air pollution. Previous 
estimates rank urban air pollution (PM2.5 
only) as the 13th leading global mortality 
risk factor and third among environmental 
risks (Ezzati et al. 2004). Our results sug-
gest a larger burden of disease due to outdoor 
air pollution than was previously estimated 
but should be compared with other risk fac-
tors only when all are updated consistently. 
Future estimates of the global burden of air 
pollution on mortality should strive to com-
bine information from global and regional 
models with rural and urban concentrations 
from measurements. These estimates should 
also incorporate CRFs from new studies on 
O3– and PM2.5–mortality relationships that 
examine individual PM2.5 components, that 
are conducted in different parts of the world, 
that include populations of all ages, and that 
resolve relationships at low and high concen-
trations. In the future, global economic devel-
opment will likely shift the disease burden 
from infectious disease and malnutrition to 
chronic conditions, which are more strongly 
affected by air pollution exposure. Although 
some countries have implemented policies to 
improve air quality, without further action 
the global burden of anthropogenic air pol-
lution on mortality may be even larger in the 
future than is estimated for the present.
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